Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 20.00
+0.04 (0.20%)
At close: Apr 22, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.19 billion as of April 22, 2026. Its market cap has increased by 1.21% in one year.
Market Cap
2.19B
Enterprise Value
1.62B
Revenue
193.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.19B, a decrease of -46.00%. That is a compound annual growth rate of -16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.19B | -16.24% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 2.97B |
| Suzhou Fushilai Pharmaceutical | 2.86B |
| Shandong Sito Bio-technology | 2.62B |
| Shanghai Hile Bio-Technology | 2.61B |
| Shanghai Universal Biotech | 2.61B |
| Jilin Jian Yisheng Pharmaceutical | 2.54B |
| Hubei Goto Biopharm | 2.50B |
| Zhejiang East Asia Pharmaceutical | 2.30B |